<DOC>
	<DOCNO>NCT01625988</DOCNO>
	<brief_summary>To assess efficacy safety LY2951742 prevention migraine headache migraineurs without aura 3 month treatment .</brief_summary>
	<brief_title>A Study LY2951742 Participants With Migraine</brief_title>
	<detailed_description>The study comprise 4 trial period : 1 . Screening washout 2 . Baseline assessment type , frequency severity headache ( 4 week ) 3 . Treatment ( 12 week ) 4 . Follow-up ( 12 week )</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Have history migraine define International Headache Society ( IHS ) International Classification Headache Disorders II guideline 1.1 1.2 ( ICHDII , Cephalgia 2004 ) least 1 year prior enrollment , migraine onset prior age 50 , moderate frequency migraine headache Women childbearing potential ( surgically sterile least 1 year postmenopause ) must test negative pregnancy time screen base serum pregnancy test must agree use reliable method birth control study 3 month follow completion participation study Have clinical laboratory test result within normal reference range , outside normal range , judge clinically significant Investigator Must migraine prevention therapy , include botulinum toxin ( Botox ) Agree post personal medical data relate study information relate study website social medium site ( example Facebook , Twitter , et cetera ) trial complete Current enrollment , discontinuation within last 30 day , clinical trial involve investigational drug device , concurrent enrollment type medical research judge scientifically medically compatible study Previous completion withdrawal study study investigate LY2951742 therapeutic antibody target calcitonin generelated peptide ( CGRP ) History chronic migraine migraine subtypes include hemiplegic ( sporadic familial ) migraine , ophthalmoplegic migraine , basilartype migraine History headache ( example , cluster headache Medication Overuse Headache ( MOH ) ) migraine tension type headache define IHS ICHDII within 12 month prior randomization Evidence significant active psychiatric disease include , limited , manic depressive illness , schizophrenia , generalize anxiety disorder , obsessive compulsive disorder , personality disorder , serious mood , anxiety , depression substance use disorder Have history presence medical illness judgment investigator , indicate medical problem would preclude study participation Women pregnant nursing Confirmed correct QT ( QTc ) interval great ( &gt; ) 470 millisecond ( msec ) woman &gt; 450 men Excessive alcohol , opiate barbiturate use ; history drug abuse dependence In opinion investigator issue would interfere compliance study requirement completion evaluation require study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>